All the Active Ingredient Drugs
Prostaglandin. Iloprost 0.1 mg/ml. AMPS (Conc. sol. for infus.): 0.5 ml.
See lit.
Periph. art. occlus. dis. (stage III and IV)
in adv. arterioscler., diabet. angiopath.,
thromboangit. obliterans (Buerger’s dis.),
Raynaud’s syndr.
C/I: Pregn., lact., hypersens. to compon.,
where effect of drug on platelets might
incr. risk of hemorrh., (e.g., active pept.
ulc., trauma, intracran. hemorrh.), severe
coron. heart dis., unstable ang., M.I.
within last 6 mths., acute or chron.
congest. heart fail., severe arrhyth.
suspect. pulm. congest.
Prostaglandin. Iloprost 0.01 mg/ml. Nebuliser soln: 30 x 2 ml. 2.5 μg inhal.
May incr. to 5 μg 6-9 x dly for 5-10
mins depend. on dose. Hepat./ren.
impair: See lit. Not for 18 yrs and
under.
Prim. pulm. hypertens., 2nd. pulm.
hypertens. due to connective tissue dis.
or drug induced mod-severe 2nd. pulm.
hypertens. due to chron. pulm.
embolism; where surg. not possible.
C/I: Hypersens., conds. when ther. may
increase risk of hemorrh., severe coron.
heart dis., unstable ang., MI within last 6
mths; decompensat. heart fail. Severe
arrhythmias, suspect. pulm. congest.,
cerebrovasc. events within last 3 mths.
Pulm. hypertens. due to venous occlus.
dis. Congen./acq. valv. defects with clin.
relevant myocard. funct. disorders not
relat. to pulm. hypertens. Pregn., lact.